register

Human Resources

Unleashing intersectionality’s transformative power to disrupt workplace diversity and inclusion practices

Health Industry Hub | May 17, 2023 |

Human Resources: In an interview with Health Industry Hub, Medicine Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs delved into the concept of intersectionality. This thought-provoking podcast with Lee Davelaar, Strategic Policy Manager at Pfizer and Jenn Jones, Head of Human Resources, Oceania at Takeda explored the complexity of individuals within organisations and how various aspects of their identity can intersect to either create privilege or contribute to oppression.

In the context of diversity, equity, and inclusion (DE&I), intersectionality plays a crucial role in recognising and addressing the unique challenges and experiences faced by individuals who belong to multiple marginalised or underrepresented groups. Lee and Jenn discussed the importance of recognising and empathising with the diverse experiences of colleagues, leading to a deeper understanding and fostering inclusivity.

Over the past year, PAIG has addressed crucial topics to drive meaningful conversations within the pharma industry. Lee shared some highlights from the previous sessions and shed light on the future focus areas.

The PAIG co-chairs shared the plans to address carer responsibility, acknowledging the challenges faced by the ‘sandwich generation’ and individuals juggling professional and personal responsibilities. Additionally, they intend to explore ableism, emphasising that disabilities, whether physical or neurodiverse, can be viewed as strengths and harnessed to contribute to organisational performance.

PAIG continues to gain momentum, with a vision to disrupt and continuously improve diversity and inclusion practices in the pharma industry. As Lee and Jenn prepare for the upcoming leader’s forum in May, they remain dedicated to shaping the next twelve months’ agenda based on member feedback and industry needs.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.